TY - JOUR
T1 - Induction of apoptosis and cellular senescence in mice lacking transcription elongation factor, Elongin A
AU - Miyata, K.
AU - Yasukawa, T.
AU - Fukuda, M.
AU - Takeuchi, T.
AU - Yamazaki, K.
AU - Sakumi, K.
AU - Tamamori-Adachi, M.
AU - Ohnishi, Y.
AU - Ohtsuki, Y.
AU - Nakabeppu, Y.
AU - Kitajima, S.
AU - Onishi, S.
AU - Aso, T.
N1 - Funding Information:
Acknowledgements. We thank T Kamura for plasmids and helpful discussions and A Tsutsui, M Tsuno, K Sugahara, J Piao and K Shiraishi for their technical assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Yamanouchi Foundation for Research on Metabolic Disorders.
PY - 2007/4
Y1 - 2007/4
N2 - Elongin A is a transcription elongation factor that increases the overall rate of mRNA chain elongation by RNA polymerase II. To gain more insight into the physiological functions of Elongin A, we generated Elongin A-deficient mice. Elongin A homozygous mutant (Elongin A-I-) embryos demonstrated a severely retarded development and died at between days 10.5 and 12.5 of gestation, most likely due to extensive apoptosis. Moreover, mouse embryonic fibroblasts (MEFs) derived from Elongin A-I- embryos exhibited not only increased apoptosis but also senescence-like growth defects accompanied by the activation of p38 MAPK and p53. Knockdown of Elongin A in MEFs by RNA interference also dramatically induced the senescent phenotype. A study using inhibitors of p38 MAPK and p53 and the generation of Elongin A-deficient mice with p53-null background suggests that both the p38 MAPK and p53 pathways are responsible for the induction of senescence-like phenotypes, whereas additional signaling pathways appear to be involved in the mediation of apoptosis in Elongin A-I- cells. Taken together, our results suggest that Elongin A is required for the transcription of genes essential for early embryonic development and downregulation of its activity is tightly associated with cellular senescence.
AB - Elongin A is a transcription elongation factor that increases the overall rate of mRNA chain elongation by RNA polymerase II. To gain more insight into the physiological functions of Elongin A, we generated Elongin A-deficient mice. Elongin A homozygous mutant (Elongin A-I-) embryos demonstrated a severely retarded development and died at between days 10.5 and 12.5 of gestation, most likely due to extensive apoptosis. Moreover, mouse embryonic fibroblasts (MEFs) derived from Elongin A-I- embryos exhibited not only increased apoptosis but also senescence-like growth defects accompanied by the activation of p38 MAPK and p53. Knockdown of Elongin A in MEFs by RNA interference also dramatically induced the senescent phenotype. A study using inhibitors of p38 MAPK and p53 and the generation of Elongin A-deficient mice with p53-null background suggests that both the p38 MAPK and p53 pathways are responsible for the induction of senescence-like phenotypes, whereas additional signaling pathways appear to be involved in the mediation of apoptosis in Elongin A-I- cells. Taken together, our results suggest that Elongin A is required for the transcription of genes essential for early embryonic development and downregulation of its activity is tightly associated with cellular senescence.
UR - http://www.scopus.com/inward/record.url?scp=33947407292&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33947407292&partnerID=8YFLogxK
U2 - 10.1038/sj.cdd.4402067
DO - 10.1038/sj.cdd.4402067
M3 - Article
C2 - 17170753
AN - SCOPUS:33947407292
SN - 1350-9047
VL - 14
SP - 716
EP - 726
JO - Cell Death and Differentiation
JF - Cell Death and Differentiation
IS - 4
ER -